FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
Viking Therapeutics (NASDAQ: VKTX) reported Q1 EPS of ($0.19), $0.02 worse than the analyst estimate of ($0.17).
Highlights from the Quarter Ended March 31, 2021:
"During the first quarter of 2021, we continued to build on the significant progress made during 2020 with both of our thyroid hormone... More

